Genetic polymorphism and natural selection in the C-terminal 42kDa region of merozoite surface protein-1 among Plasmodium vivax Korean isolates

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Kang, Jung Mi ^a   Ju, Hye Lim ^a   Kang, Yoo Mi ^a   Lee, Dong Hyun ^a   Moon, Sung Ung ^b   Sohn, Woon Mok ^a   Park, Jae Won ^c   Kim, Tong Soo ^d   Na, Byoung Kuk ^a  

^a Gyeongsang National University School of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Gachon University College of Medicine   (South Korea)

^d Inha University School of Medicine   (South Korea)

Author keywords

Genetic diversity; Korea; Merozoite surface protein 1C terminal 42kDa fragment; Natural selection; Plasmodium vivax

Indexed keywords

MEROZOITE SURFACE PROTEIN 1; PROTOZOAL DNA;

ARTICLE; BLOOD SAMPLING; ESCHERICHIA COLI; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC RECOMBINATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MOLECULAR CLONING; NATURAL SELECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; AMINO ACID SEQUENCE; BLOOD; CHEMISTRY; CLUSTER ANALYSIS; DNA SEQUENCE; GENETIC SELECTION; GENETICS; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; MUTATION; PARASITOLOGY; PHYLOGENY; PLASMODIUM VIVAX MALARIA;

AMINO ACID SEQUENCE; BLOOD; CLONING, MOLECULAR; CLUSTER ANALYSIS; DNA, PROTOZOAN; HUMANS; KOREA; MALARIA, VIVAX; MEROZOITE SURFACE PROTEIN 1; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECOMBINATION, GENETIC; SELECTION, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 84862264953     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-206     Document Type: Article

References (46)

1. Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria. Holder AA, Guevara Patino JA, Uthaipibull C, Syed SE, Ling IT, Scott-Finnigan T, Blackman MJ, Parasitologia 1999 41 409 414 (Pubitemid 129640287)
2. The precursor to major merozoite surface antigens: Structure and role in immunity. Holder AA, Prog Allergy 1988 41 72 97 3043424
3. Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. Blackman MJ, Ling LT, Nicholls SC, Holder AA, Mol Biochem Parasitol 1991 49 29 34 10.1016/0166-6851(91)90127-R 1775158
4. Secondary processing of the Plasmodium falciparum merozoite surface protein-1 (MSP1) by a calcium-dependent membrane-bound serine protease: shedding of MSP-133 as a noncovalently associated complex with other fragments of the MSP1. Blackman MJ, Holder AA, Mol Biochem Parasitol 1992 50 307 315 10.1016/0166-6851(92)90228-C 1741018
5. Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria. Soares IS, Levitus G, Souza JM, Del Portillo HA, Rodrigues MM, Infect Immun 1997 65 1606 1614 9125537 (Pubitemid 27193576)
6. Naturally acquired antibody responses to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in Korea. Park JW, Moon SH, Yeom JS, Lim KJ, Sohn MJ, Jung WC, Cho YJ, Jeon KW, Ju W, Ki CS, Oh MD, Choe K, Clin Diagn Lab Immunol 2001 8 14 20 11139190 (Pubitemid 32061679)
7. Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli. Sachdeva S, Ahmad G, Malhotra P, Mukherjee P, Chauhan VS, Infect Immun 2004 72 5775 5782 10.1128/IAI.72.10.5775-5782.2004 15385477 (Pubitemid 39303688)
8. IgG antibody profile to c-terminal region of Plasmodium vivax merozoite surface protein-1 in Thai individuals exposed to malaria. Pitabut N, Panichakorn J, Mahakunkijcharoen Y, Hirunpetcharat C, Looareesuwan S, Khusmith S, Southeast Asian J Trop Med Public Health 2007 38 1 7 18637404
9. Naturally acquired IgM antibody response to the C-terminal region of the merozoite surface protein 1 of Plasmodium vivax in Korea: use for serodiagnosis of vivax malaria. Yeom JS, Kim ES, Lim KJ, Oh JH, Sohn MJ, Yoo SB, Kim E, Bae I, Jung YJ, Park JW, J Parasitol 2008 94 1410 1414 10.1645/GE-1484.1 18576813
10. Analysis of naturally acquired antibody responses to the 19-kd C-terminal region of merozoite surface protein-1 of Plasmodium vivax from individuals in Sanliurfa, Turkey. Zeyrek FY, Babaoglu A, Demirel S, Erdogan DD, Ak M, Korkmaz M, Coban C, Am J Trop Med Hyg 2008 78 729 732 18458304 (Pubitemid 351845127)
11. Characterization with monoclonal antibodies of a surface antigen of Plasmodium falciparum merozoites. Pirson PJ, Perkins ME, J Immunol 1985 134 1946 1951 3881529 (Pubitemid 15128966)
12. A single fragment of a malaria merozoite surface protein remains on the parasite during red blood cell invasion and is the target of invasion-inhibiting antibodies. Blackman MJ, Heidrich HG, Donachie S, McBridge JS, Holder AA, J Exp Med 1990 172 379 382 10.1084/jem.172.1.379 1694225 (Pubitemid 20217284)
13. A carboxyl-terminal fragment of Plasmodium falciparum gp 195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth. Chang SP, Gibson HL, Lee NC, Barr PJ, Hui GS, J Immunol 1992 149 548 555 1624802
14. Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognize the first growth factor-like domain of merozoite surface protein-1. Chappel JA, Holder AA, Mol Biochem Parasitol 1993 60 303 312 10.1016/0166-6851(93)90141-J 7694147
15. A protective monoclonal antibody recognizes a variant-specific epitope in the precursor of the major merozoite surface antigen of the rodent malarial parasite Plasmodium yoelii. Burns JM, Parke LA, Daly TM, Cavacini LA, Weidanz WP, Long CA, J Immunol 1989 142 2835 2840 2467942 (Pubitemid 19114903)
16. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice. Devi YS, Mukherjee P, Yazdani SS, Shakri AR, Mazumdar S, Pandey S, Chitnis CE, Chauhan VS, Vaccine 2007 25 5166 5174 10.1016/j.vaccine.2007.04.080 17544179 (Pubitemid 46907376)
17. Merozoite surface protein 1 of Plasmodium vivax induces a protective response against Plasmodium cynomolgi challenge in rhesus monkeys. Dutta S, Kaushal DC, Ware LA, Puri SK, Kaushal NA, Narula A, Upadhyaya DS, Lanar DE, Infect Immun 2005 73 5936 5944 10.1128/IAI.73.9.5936-5944.2005 16113314 (Pubitemid 41193032)
18. Plasmodium vivax: who cares? Galinski BR, Barnwell JW, Malar J 2008 7 (Suppl:S9)
19. Malaria vaccines: where next? Holder A, PLoS Pathog 2009 5 1000638 10.1371/journal.ppat.1000638 19876389
20. Synopsis of the world Malaria situation in 1979. World Health Organization, Wkly Epidemiol Rec 1981 56 145 149
21. Plasmodium vivax malaria: status in the Republic of Korea following reemergence. Park JW, Jun G, Yeom JS, Korean J Parasitol 2009 47 Suppl 39 S50 10.3347/kjp.2009.47.S.S39 19885334
22. Vivax malaria: A continuing health threat to the Republic of Korea. Park JW, Klein TA, Lee HC, Pacha LA, Ryu SH, Yeom JS, Moon SH, Kim TS, Chai JY, Oh MD, Choe KW, Am J Trop Med Hyg 2003 69 159 167 13677372
23. Plasmodium vivax malaria in the Republic of Korea during 2004-2005: Changing patterns of infection. Yeom JS, Kim TS, Oh S, Sim JB, Barn JS, Kim HJ, Kim YA, Ahn SY, Shin MY, Yoo JA, Park JW, Am J Trop Med Hyg 2007 76 865 868 17488906 (Pubitemid 351627670)
24. Analysis of Plasmodium vivax merozoite surface protein-1 gene sequences from resurgent Korean isolates. Lim CS, Kim SH, Kwon SI, Song JW, Song KJ, Lee KN, Am J Trop Med Hyg 2000 62 261 265 10813482 (Pubitemid 30257587)
25. Molecular genetic characterization of the merozoite surface protein 1 gene of Plasmodium vivax from reemerging Korean isolates. Kim SH, Hwang SY, Shin JH, Moon CS, Kim DW, Kho WG, Clin Vaccine Immunol 2009 16 733 738 10.1128/CVI.00493-08 19261779
26. Rapid dissemination of newly introduced Plasmodium vivax genotypes in South Korea. Choi YK, Choi KM, Park MH, Lee EG, Kim YJ, Lee BC, Cho SH, Rhie HG, Lee HS, Yu JR, Lee JS, Kim TS, Kim JY, Am J Trop Med Hyg 2010 82 426 432 10.4269/ajtmh.2010.09-0245 20207868
27. High frequency of genetic diversity of Plasmodium vivax field isolates in Myanmar. Moon SU, Lee HW, Kim JY, Na BK, Cho SH, Lin K, Sohn WM, Kim TS, Acta Trop 2009 109 30 36 10.1016/j.actatropica.2008.09.006 18851938
28. Genetic diversity in the C-terminal 42kDa region of merozoite surface protein-1 of Plasmodium vivax (PvMSP-142) among Indian isolates. Thakur A, Alam MT, Sharma YD, Acta Trop 2008 108 58 63 10.1016/j.actatropica.2008.08.011 18823930
29. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Tamura K, Dudley J, Nei M, Kumar S, Mol Biol Evol 2007 24 1596 1599 10.1093/molbev/msm092 17488738 (Pubitemid 47236692)
30. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Librado P, Rozas J, Bioinformatics 2009 25 1451 1452 10.1093/bioinformatics/ btp187 19346325
31. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Nei M, Gojobori T, Mol Biol Evol 1986 3 418 426 3444411 (Pubitemid 16010523)
32. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Tajima F, Genetics 1989 123 585 595 2513255 (Pubitemid 19274682)
33. Statistical tests of neutrality of mutations. Fu YX, Li WH, Genetics 1993 133 693 709 8454210
34. Blood stage vaccines for Plasmodium falciparum: current status and the way forward. Ellis RD, Sagara I, Doumbo O, Wu Y, Hum Vaccin 2010 6 627 634 10.4161/hv.6.8.11446 20519960
35. Phase 1 study of two merozoite surface protein 1 (MSP 142) vaccines for Plasmodium falciparum malaria. Malkin E, Long CA, Stowers AW, Zou L, Singh S, MacDonald NJ, Narum DL, Miles AP, Orcutt AC, Muratova O, Moretz SE, Zhou H, Diouf A, Fay M, Tierney E, Leese P, Mahanty S, Miller LH, Saul A, Martin LB, PLoS Clin Trial 2007 2 12 10.1371/journal.pctr.0020012 (Pubitemid 46851661)
36. Ex vivo cytokine and memory T cell responses to the 42-kDa fragment of Plasmodium falciparum merozoite surface protein-1 in vaccinated volunteers. Huaman MC, Martin LB, Malkin E, Narum DL, Miller LH, Mahanty S, Long CA, J Immunol 2008 180 1451 1461 18209040
37. Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in western Kenya. Ogutu BR, Apollo OJ, McKinney D, Okoth W, Siangla J, Dubovsky F, Tucker K, Waitumbi JN, Diggs C, Wittes J, Malkin E, Leach A, Soisson LA, Milman JB, Otieno L, Holland CA, Polhemus M, Remich SA, Ockenhouse CF, Cohen J, Ballou WR, Martin SK, Angov E, Stewart VA, Lyon JA, Heppner DG, Withers MR, MSP-1 Malaria Vaccine Working Group, PLoS One 2009 4 4708 10.1371/journal.pone.0004708 19262754
38. Dimorphism of the C-terminus of the Plasmodium vivax merozoite surface protein-1. Pasay MC, Cheng Q, Rzepczyk C, Saul A, Mol Biochem Parasitol 1995 70 217 219 10.1016/0166-6851(95)00015-S 7637707
39. A Plasmodium vivax vaccine candidate displays limited allele polymorphism, which does not restrict recognition by antibodies. Soares IS, Barnwell JW, Ferreira MU, Gomes Da Cunha M, Laurino JP, Laurino JP, Castilho BA, Rodrigues MM, Mol Med 1999 5 459 470 10449807 (Pubitemid 29399751)
40. Intragenic recombination in the 30 portion of the merozoite surface protein-1 gene of Plasmodium vivax. Putaporntip C, Jongwutiwes S, Seethamchai S, Kanbara H, Tanabe K, Mol Biochem Parasitol 2000 109 111 119 10.1016/S0166-6851(00)00238-3 10960170 (Pubitemid 30665408)
41. Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locus. Putaporntip C, Jongwutiwes S, Sakihama N, Ferreira MU, Kho WG, Kaneko A, Kanbara H, Hattori T, Tanabe K, Proc Natl Acad Sci USA 2002 99 16348 16353 10.1073/pnas.252348999 12466500 (Pubitemid 35462798)
42. Genetic diversity and recombination at the C-terminal fragment of the merozoite surface protein-1 of Plasmodium vivax (PvMSP-1) in Sri Lanka. Dias S, Longacre S, Escalante AA, Udagama-Randeniya PV, Infect Genet Evol 2011 11 145 156 10.1016/j.meegid.2010.09.007 20933611
43. Recent increase of genetic diversity in Plasmodium vivax population in the Republic of Korea. Honma H, Kim JY, Palacpac NM, Mita T, Lee W, Horii T, Tanabe K, Malar J 2011 10 257 10.1186/1475-2875-10-257 21899730
44. A comparative study of the genetic diversity of the 42 kDa fragment of the merozoite surface protein-1 in Plasmodium falciparum and P. vivax. Pacheco MA, Poe AC, Collins WE, Lal AA, Tanabe K, Kariuki SK, Udhayakumar V, Escalante AA, Infect Genet Evol 2007 7 180 187 10.1016/j.meegid.2006.08.002 17010678 (Pubitemid 46172945)
45. Assessing the effect of natural selection in malaria parasites. Escalante AA, Cornejo OE, Rojas A, Udhayakumar V, Lal AA, Trends Parasitol 2004 20 388 395 10.1016/j.pt.2004.06.002 15246323 (Pubitemid 38916529)
46. Molecular aspects of severe malaria. Chen Q, Schlichtherle M, Wahlgren M, Clin Microbiol Rev 2000 13 439 450 10.1128/CMR.13.3.439-450.2000 10885986 (Pubitemid 30452616)